ATON
ATON
NASDAQ · Biotechnology

Alphaton Capital Corp

Penny Stocks Biotech Stocks Healthcare Stocks
$0.54
+0.04 (+8.79%)
As of Feb 8, 2:30 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +2,155.6% upside
Low Target $6.99
Average Target $12.09
High Target $15.02
Current Price $0.54
Current
$0.54
Target
$12.09
$6.99 $12.09 avg $15.02
Scenario Analysis
Bear Case
$6.99
1,204.1%
Low target
Base Case
$12.09
+2,155.6%
Avg target
Bull Case
$15.02
+2,702.2%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$11.04
-95.1% from high
52-Week Low
$6.33
+-91.5% from low
Target vs 52W High
$12.09
+9.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%